-
HIV Drugs Market Outlook: Future Trends Indicate a US$ 47.5 Billion Industry by 2034 with a Shift Toward Single-dose Regimens | Report by TMR
18 Mar 2025 11:28 GMT
… Merck initiated clinical trials for its next-generation HIV treatment targeting drug … and ART medications.
Government … Merck & Co., Inc.
Isentress … HIV treatment
Teva Pharmaceutical Industries Ltd.
Generic ARVs, Lamivudine, Zidovudine
Growth in cos
HIV Drugs …
-
Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results
04 Feb 2025 13:04 GMT
… FDA Granted Priority Review to Merck’s Application for WELIREG for the Treatment … Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, … are provided below.
Pharmaceutical
BRIDION (sugammadex)
CAPVAXIVE …
-33
-28
Isentress/Isentress HD
111
89
…
-
HIV Treatment Information for Pregnant Women
30 Jan 2025 20:04 GMT
… and are virologically suppressed (HIV-1 RNA less than 50 … and are virologically suppressed (HIV-1 RNA less than 50 … available for the approved treatment dose of 600 mg … information available
Human Data
Isentress Label
Isentress HD
raltegravir 600 mg …
-
Second Woman May Be Cured of HIV After Stem Cell Transplant
01 Jan 2025 05:31 GMT
… HIV after receiving a stem cell transplant for cancer treatment … report presented at the HIV Drug Therapy meeting in Glasgow. … match, she also received medication to prevent graft-versus … she was taking raltegravir (Isentress) and tenofovir disoproxil fumarate…
-
Human Immunodeficiency Virus Type-1 Market Report 2034: Epidemiology Data, Therapies, FDA Approvals by DelveInsight
18 Dec 2024 17:46 GMT
… Merck, ViiV Healthcare, Gilead Sciences, Janssen Pharmaceuticals, … , CytoDyn, Frontier Biotechnologies, Aelix Therapeutics
Human … medications for the treatment of HIV-1 include drugs like Pifeltro, Isentress … HIV treatments are currently in clinical trials, …
-
USFDA grants tentative approval to Lupin’s generic formulation to treat HIV infection
08 Nov 2024 13:56 GMT
… States Food and Drug Administration (U.S. FDA) for its … Abbreviated New Drug Application for Raltegravir … equivalent of Isentress HD Tablets, 600 mg of Merck Sharp … agents for the treatment of human immunodeficiency virus (HIV-1) infection …
-
Merck Announces Third-Quarter 2024 Financial Results
31 Oct 2024 10:44 GMT
… 3 Clinical Trial for MK-3000 for the Treatment of … its medicines and vaccines through commercial channels, clinical trials, voluntary … names are provided below.
Pharmaceutical
BRIDION (sugammadex)
CAPVAXIVE ( … -36
-32
-27
Isentress/Isentress HD
111
89
102
…
-
Isentress side effects: What you should know
22 Oct 2024 13:04 GMT
… took Isentress in clinical trials:
dizziness … doctor or pharmacist.
Note: After the Food and Drug Administration (FDA) approves a drug … start taking HIV medications, including Isentress. HIV medications can help … to continue treatment with Isentress.
Below is …
-
27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
27 Sep 2024 16:15 GMT
… licensed pharmaceutical distribution channels. By selling diverted prescription drugs and … Hydrochloride, Incruse Ellipta, Invokamet, Invokana, Isentress, Janumet, Januvia, Jardiance, Jentadueto, … on the FDA website. If someone is having a medical emergency, …
-
Merck Announces Second-Quarter 2024 Financial Results
30 Jul 2024 11:05 GMT
… drug conjugate being developed by Merck in collaboration with Kelun-Biotech … Trial Met Dual Primary Endpoint of OS as First-Line Treatment … names are provided below.
Pharmaceutical
BRIDION (sugammadex)
CAPVAXIVE … 42
-23
-18
Isentress/Isentress HD
111
89
200 …